Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2008, Pages

  Mosalli, Rafat ^a   Alfaleh, K ^b  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEATH; DISEASE SEVERITY; HUMAN; LIGATION; LOW BIRTH WEIGHT; LUNG DYSPLASIA; MORBIDITY; MORTALITY; NECROTIZING ENTEROCOLITIS; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; POSTOPERATIVE COMPLICATION; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RETROLENTAL FIBROPLASIA; REVIEW; SEPSIS;

EID: 44949090539     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006181.pub2     Document Type: Review

References (40)

1. Cassady 1989 {published data only} Cassady G, Crouse DT, Kirklin JW, Strange MJ, Joiner CH, Godoy G, et al.A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. New England Journal of Medicine 1989;320:1511-6.
2. Cotton 1978 Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. Journal of Pediatrics 1978;93:647-51.
3. AlFaleh 2004 Al-Faleh K, Smyth JA, Roberts RA, Solimano A, Asztalos EV, Schmidt B. Prevention and 18-month outcome of serious pulmonary hemorrhage in extremely-low-birth-weight (ELBW) infants: results from the trial of indomethacin prophylaxis in preterms (TIPP). EPAS (Pediatric Academic Societies) 2004:Abstract 2589.
4. Bancalari 2003 Bancalari E, Claure N, Sosenko IR. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Seminars in Neonatology 2003;1:63-71.
5. Bayley 1993 Bayley N. Manual for the Bayley Scales of Infant Development. 2nd Edition. San Antonio, Tex.: Psychological Corporation, 1993.
6. Bell 1978 Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, Brotherton T. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery 1978;187:1-7.
7. Brook 1995 Brook M, Heymann M. Patent ductus arteriosus. In: EmmanouilidesGC, RiemenschneiderTA, AllenHD, GutgesellHP editor(s). Heart Disease in Infants, Children and Adolescents Including the Fetus and Young Adult. Williams & Wilkins, 1995:746-64.
8. Brown 1979 Brown ER. Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. The Journal of Pediatrics 1979;95:865-6.
9. Chen 1999 Chen KB, Tu KT, Cheng HC, Wu YL, Chang JS. The anesthetic management of a preterm infant weighing 500 gms undergoing ligation of patent ductus arteriosus. Acta Anaesthesiologica Sinica 1999;37:89-92.
10. Clyman 1990 Clyman R. Developmental physiology of the ductus arteriosus. In: LongW editor(s). Fetal and Neonatal Cardiology. Philadelphia: WB Saunders, 1990:64-75.
11. Clyman 1996 Clyman RI. Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. Journal of Pediatrics 1996;128:601-7.
12. Clyman 1998 Clyman RI, Waleh N, Black SM. Regulation of ductus arteriosus patency by nitric oxide in fetal lambs: the role of gestation, oxygen tension, and vasa vasorum. Pediatric Research 1998;43:633-44.
13. Clyman 2000 Clyman R, Narayanan M. Patent ductus arteriosus: a physiologic basis for current treatment practices. Current Topics in Neonatology. Philadelphia: WB Saunders, 2000:71-91.
14. Cotton 1979 Cotton RB, Stahlman MT, Kovar I, Catterton WZ. Medical management of small preterm infants with symptomatic patent ductus arteriosus. The Journal of Pediatrics 1979;2:467-73.
15. Duddell 1984 Duddell GG, Gersony M. Patent ductus arteriosus in neonates with severe respiratory disease. Journal of Pediatrics 1984;104:915-20.
16. Fowlie 2002 Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database of Systematic Reviews 2002, Issue 4.Art. No.: CD000174. DOI:10.1002/14651858.CD000174.
17. Hammerman 1995 Hammerman C. Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment. Clinics of Perinatology 1995;22:457-79.
18. Kabra 2007 Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. Journal of Pediatrics 2007;150:229-34.
19. Kitterman 1972 Kitterman JA, Edmunds LH, Gregory GA, Heymann MA, Tooley H, Rudolph AM. Patent ductus arteriosus in premature infants: incidence and relation to pulmonary disease and management. New England Journal of Medicine 1972;287:473-7.
20. Kluckow 2000 Kluckow M, Evans N. Ductal shunting, high pulmonary blood flow and pulmonary hemorrhage. Journal of Pediatrics 2000;137:68-72.
21. Laughon 2007 Laughon M, Bose C, Clark R. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes. Journal of Perinatology 2007;27:164-70.
22. Laughon 2004 Laughon MM, Simmons MA, Bose CL. Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated?. Current Opinion in Pediatrics 2004;16:146-51.
23. Malviya 2003 Malviya M, Ohlsson A, Shah S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database of Systematic Reviews 2003, Issue 3.Art. No.: CD003951. DOI: 10.1002/14651858.CD003951.pub2.
24. Martin 1982 Martin CG, Snider AR, Katz SM, Peabody JL, Brady JP. Abnormal cerebral flow patterns in preterm infants with a large patent ductus arteriosus. Journal of Pediatrics 1982;101:587-93.
25. Mouzinho 1991 Mouzinho AI, Rosenfeld CR, Risser R. Symptomatic patent ductus arteriosus in very low birth weight infants. Early Human Development 1991;27:65-77.
26. Nestrud 1980 Nestrud RM, Hill DE, Arrington RW, Beard AG, Dungan WT, Norton JB, Radinger RI. Indomethacin treatment in patent ductus arteriosus: a double blind study utilizing indomethacin plasma levels. Developmental Pharmacology and Therapeutics 1980;1:125-36.
27. Osborn 2003 Osborn DA, Evans N, Kluckow M. Hemodynamic and antecedent risk factors of early and late periventricular/intraventricular hemorrhage in premature infants. Pediatrics 2003;112:33-9.
28. Osborn DA 2003 Osborn DA, Evans N, Kluckow M. Effect of early targeted indomethacin on the ductus arteriosus and blood flow to the upper body and brain in the preterm infant. Archives of Disease in Childhood 2003;88:F477-82.
29. Palder 1987 Palder SB, Schwartz M, Tyson K, Marr C. Management of patent ductus arteriosus: comparison of operative vs pharmacologic treatment. Journal of Pediatric Surgery 1987;22:1171-4.
30. Papile 1978 Papile LA, Burstein J, Burstein R, Kofer H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. Journal of Pediatrics 1978;92:529-34.
31. Pokharel 1998 Pokharel R, Hisano K, Yasufuku M, Ataka K, Okada M, Yoshimoto S. Ligation of medically refracted patent ductus arteriosus (PDA) in an extremely low body weight premature infant. Surgery Today 1998;28:1290-4.
32. Reller 1993 Reller MD, Rice MJ, McDonald RW. Review of studies evaluating ductal patency in the premature infant. Journal of Pediatrics 1993;122:S59-62.
33. Rojas 1995 Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G, et al.Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. Journal of Pediatrics 1995;126:605- 10.
34. Satur 1991 Satur CR, Walker DR, Dickinson DF. Day case ligation of patent ductus arteriosus in preterm infants. A ten year review. Archives of Disease in Childhood 1991;66:477-80.
35. Schmidt 2001 Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, et al.Long-term effects of indomethacin prophylaxis in extremely low-birth-weight infants. New England Journal of Medicine 2001;344:1966-72.
36. Shimada 1994 Shimada S, Kasai T, Konishi M, Fujiwara T. Effects of patent ductus arteriosus on left ventricular output and oxygen blood flow in preterm infants with respiratory distress syndrome treated with surfactant. Journal of Pediatrics 1994;125:270-7.
37. Teixeira 2006 Teixeira L, McNamara P. Enhanced intensive care for the neonatal ductus arteriosus. Acta Paediatrica 2006;95:394-403.
38. Trus 1993 Trus T, Winthrop AL, Pipe S, Shah J, Langer JC, Lau GY. Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g. Journal of Pediatric Surgery 1993;28:1137-9.
39. Wagner 1984 Wagner HR, Ellison C, Zierler S, Lang P, Purohit DM, Behrendt D, et al.Surgical closure of patent ductus arteriosus in 268 preterm infants. Journal of Thoracic and Cardiovascular Surgery 1984;87:870-5.
40. Weir 1999 Weir FJ, Ohlsson A, Myhr TL, Fong K, Rayan ML. A patent ductus arteriosus is associated with reduced middle cerebral artery blood flow velocity. European Journal of Pediatrics 1999;158:484-7.